Top View
- Biology and Treatment of Acute Lymphoblastic Leukemia Rob Pieters, MD, Msc, Phda,*, William L
- Peripheral T-Cell Lymphoma: Pharmacotherapy Overview
- Customs Tariff - Schedule
- From Cell Biology to Therapy: Forodesine
- A Review of the Role of Puma, Noxa and Bim in the Tumorigenesis, Therapy and Drug Resistance of Chronic Lymphocytic Leukemia
- Treatment of Adult T-Cell Leukemia
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Individual Tumor Response Testing in Multiple Relapsed Acute Myeloid Leukemia in Children
- Expert's Comment
- Forodesine in the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma: an Evidence-Based Review
- Skin Diseases Affecting Americans
- 1 Protoporphyrin IX Is a Dual Inhibitor of P53/MDM2 and P53/MDM4
- Safety and Efficacy of Forodesine for a Recurrent Peripheral T-Cell
- Development of Fludarabine Formulations in the Treatment of Chronic Lymphocytic Leukemia
- Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
- The European Leukemianet: Achievements and Perspectives
- Ancient Roots of Modern Medicines; Their Prospects and Promises
- Treatment of Adult T-Cell Leukemia
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
- Orphan Drugs in Asia Report 2014
- Pharmacokinetics Uses and Administration Adverse Effects And
- Qualifying Therapeutic Discovery Project Grants
- The European Union Paediatric Medicine Regulation
- Hematology Drugs in the Pipeline
- Hematology Drugs in the Pipeline
- Namal Vikum Carlo Coorey
- Oncology Drugs in the Pipeline
- Differences Between Intrinsic and Acquired Nucleoside Analogue
- Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
- Medicines & Vaccines in Development for Cancer
- Download.Html (Accessed on 23 February 2021)
- Characterization of Newly Established Pralatrexate-Resistant Cell Lines and the Mechanisms of Resistance
- Oncology Drugs in the Pipeline
- Relapsed Refractory Nodal Peripheral T-Cell Lymphoma With
- Novel Approaches for Therapy of Resistant Acute Lymphoblastic Leukemia
- Resistant Cell Lines and the Mechanisms of Resistance
- Chemotherapy for Leukemia Takanori Ueda Editor
- Multicenter Phase 1/2 Study of Forodesine in Patients with Relapsed Peripheral T Cell Lymphoma
- (12) United States Patent (10) Patent No.: US 8,946,224 B2 Craighead Et Al
- Mesenchymal Stem Cells As a Double-Edged Sword in Tumor Growth